BeOne Medicines (ONC) Shareholder's Equity (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.15% |
| Dec 31, 2025 | 5.62% |
| Sep 30, 2025 | 9.52% |
| Jun 30, 2025 | 7.74% |
| Mar 31, 2025 | 5.02% |
| Dec 31, 2024 | -3.02% |
| Sep 30, 2024 | 2.07% |
| Jun 30, 2024 | 0.18% |
| Mar 31, 2024 | -5.00% |
| Dec 31, 2023 | -6.00% |
| Sep 30, 2023 | -0.93% |
| Jun 30, 2023 | -8.63% |
| Mar 31, 2023 | -5.16% |
| Dec 31, 2022 | -5.84% |
| Sep 30, 2022 | -10.42% |
| Jun 30, 2022 | -10.00% |
| Mar 31, 2022 | -5.84% |
| Dec 31, 2021 | 82.68% |
| Sep 30, 2021 | -6.92% |
| Jun 30, 2021 | -9.91% |
| Mar 31, 2021 | 3.47% |
| Dec 31, 2020 | -9.76% |
| Sep 30, 2020 | 68.37% |
| Jun 30, 2020 | -9.92% |
| Mar 31, 2020 | 188.96% |
| Dec 31, 2019 | -24.41% |
| Sep 30, 2019 | -17.63% |
| Jun 30, 2019 | -3.17% |
| Mar 31, 2019 | -7.47% |
| Dec 31, 2018 | -11.59% |
| Sep 30, 2018 | 61.69% |
| Jun 30, 2018 | -9.72% |
| Mar 31, 2018 | 98.58% |
| Dec 31, 2017 | -8.79% |
| Sep 30, 2017 | 177.65% |
| Jun 30, 2017 | -12.40% |
| Mar 31, 2017 | -12.61% |
| Dec 31, 2016 | 87.88% |
| Sep 30, 2016 | -14.64% |
| Jun 30, 2016 | -9.48% |
| Mar 31, 2016 | 338.88% |